Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hepatic Impairment × capmatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 cMET-dysregulated Advanced Solid Tumors 2 Glioblastoma 2 Colorectal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Laryngeal Diseases 1 Hepatic Impairment 1 Gliosarcoma 1 EGFR-mutant Non-small Cell Lung Cancer 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Advanced Solid Tumor 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02474537 2020-12-10

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

Novartis

Phase 1 Completed

Hepatic Impairment

Data powered by HemOnc (CC BY 4.0) Colophon ⚡